XML 17 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Restructuring
9 Months Ended
Sep. 30, 2015
Restructuring and Related Activities [Abstract]  
Restructuring
Restructuring
The Company recorded restructuring charges during the three and nine months ended September 30, 2015 in connection with a reduction in force, the departure of certain executive officers and management's further alignment of the business with strategic objectives. These charges related to severance arrangements with departing employees and executives, including those impacted by the closing of its fabrication facility in McKeesport, Pennsylvania and the termination of the operations of a foreign subsidiary that was involved in the development of certain data analytics and monitoring products (see Note 3), as well as non-cash charges related to the acceleration of vesting of certain stock awards. The Company incurred additional charges during the remainder of 2015 associated with the closing of BCSI's facilities and corresponding alignment of the business with strategic objectives.

The Company recorded restructuring charges during the three and nine months ended September 30, 2014 primarily related to a reduction in force, the departure of executive officers and management's alignment of the business with strategic objectives. These charges were related to severance agreements with departing employees and executives, including non-cash charges related to the acceleration of vesting of certain stock awards.
A summary of the net pretax charges, incurred by segment, for each period is as follows:
 
 
 
 
Pretax Charge
(in thousands, except employee data)
 
Approximate Number of Employees
 
Refined Coal
 
Emission Control - ACI
 
Emissions Control - BCSI
 
Research & Development
 
All Other and Corporate
 
Total
Three Months Ended September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring charges
 
109

 
$

 
$
316

 
$
364

 
$
1,937

 
$
116

 
$
2,733

Total pretax charge, net of reversals
 
 
 
$

 
$
316

 
$
364

 
$
1,937

 
$
116

 
$
2,733

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2015
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring charges
 
154

 
$

 
$
2,030

 
$
364

 
$
2,023

 
$
4,358

 
$
8,775

Changes in estimates
 
 
 

 
(10
)
 

 

 
(2
)
 
(12
)
Total pretax charge, net of reversals
 
 
 
$

 
$
2,020

 
$
364

 
$
2,023

 
$
4,356

 
$
8,763

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring charges
 
5

 
$

 
$
408

 
$

 
$

 
$
1,598

 
$
2,006

Total pretax charge, net of reversals
 
 
 
$

 
$
408

 
$

 
$

 
$
1,598

 
$
2,006

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended September 30, 2014
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Restructuring charges
 
23

 
$

 
$
760

 
$

 
$

 
$
1,612

 
$
2,372

Total pretax charge, net of reversals
 
 
 
$

 
$
760

 
$

 
$

 
$
1,612

 
$
2,372



The following table summarizes the Company’s utilization of restructuring accruals for the nine months ended September 30, 2015:
(in thousands)
 
Employee Severance
 
Business Operations Closure
 
Total
Remaining accrual as of December 31, 2014
 
$
1,690

 
$

 
$
1,690

Expense provision (1)
 
6,902

 
1,873

 
8,775

Cash payments and other (1)
 
(5,502
)
 
(1,873
)
 
(7,375
)
Change in estimates
 
(12
)
 

 
(12
)
Remaining accrual as of September 30, 2015
 
$
3,078

 
$

 
$
3,078


(1) Included within the Expense provision and Cash payments and other line items in the above table is equity based compensation of $3.1 million for the nine months ended September 30, 2015, resulting from the accelerated vesting of modified equity-based compensation awards for certain terminated employees. Additionally, as discussed in Note 3, due to restructuring activities the Company fully impaired the carrying value of certain assets, thereby recognizing net impairment expense in the amount of $1.9 million during the third quarter of 2015.

Restructuring accruals are included within the Accrued payroll and related liabilities line item in the Condensed Consolidated Balance Sheets. Restructuring expenses are included within the Payroll and benefits and Research and development, net line items in the Condensed Consolidated Statements of Operations.